CVKD
insider transactionsCadrenal Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-56.6K
0 buy · 56.6K sell
Net value · 30d
-$230.8K
$0 in · $230.8K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
14
0 buy · 56.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO · 10b5-1
$1.6K
513 sh · $3.16
Own -0%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO · 10b5-1
$11.5K
3.6K sh · $3.18
Own -3%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO
$13.1K
3.7K sh · $3.58
Own -3%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO
$51.2K
13.0K sh · $3.94
Own -9%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO
$6.0K
1.5K sh · $4.12
Own -1%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO · 10b5-1
$14.7K
3.5K sh · $4.21
Own -2%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO · 10b5-1
$52.7K
13.0K sh · $4.06
Own -8%
-
Sell·S
Quang X Pham KEY
Chairman, CEO and Interim CFO · 10b5-1
$25.8K
5.9K sh · $4.38
Own -3%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$9.1K
2.1K sh · $4.42
Own -1%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$17.2K
3.9K sh · $4.41
Own -2%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$9.9K
2.3K sh · $4.26
Own -1%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$1.6K
349 sh · $4.46
Own -0%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$1.5K
303 sh · $5.01
Own -0%
-
Sell·S
Quang X Pham KEY
CEO and Chairman · 10b5-1
$14.7K
3.0K sh · $4.93
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 513 | $1.6K |
| Jun 16, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 3.6K | $11.5K |
| Jun 15, 2026 | Quang X Pham KEY | Sell S | 3.7K | $13.1K |
| Jun 12, 2026 | Quang X Pham KEY | Sell S | 13.0K | $51.2K |
| Jun 11, 2026 | Quang X Pham KEY | Sell S | 1.5K | $6.0K |
| Jun 10, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 3.5K | $14.7K |
| Jun 9, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 13.0K | $52.7K |
| Jun 8, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 5.9K | $25.8K |
| Jun 5, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 2.1K | $9.1K |
| Jun 4, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 3.9K | $17.2K |
| Jun 3, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 2.3K | $9.9K |
| Jun 2, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 349 | $1.6K |
| May 29, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 303 | $1.5K |
| May 28, 2026 | Quang X Pham KEY 10b5-1 | Sell S | 3.0K | $14.7K |
About CVKD insider trading
This page tracks insider transactions for Cadrenal Therapeutics, Inc. (CVKD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.